Travere Therapeutics (TVTX) PT Raised to $62 at Stifel
Tweet Send to a Friend
(Updated - August 5, 2026 11:14 AM EDT)
Stifel analyst Alex Thompson raised the price target on Travere Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Alex Thompson raised the price target on Travere Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
